Shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.60. Xtant Medical shares last traded at $0.57, with a volume of 13,702 shares traded.
Xtant Medical Price Performance
The company has a market cap of $74.62 million, a PE ratio of -57.26 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.44 and a quick ratio of 1.01.
Xtant Medical (NYSEAMERICAN:XTNT – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The medical device company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.01). The company had revenue of $29.94 million for the quarter. Xtant Medical had a negative net margin of 3.00% and a negative return on equity of 6.71%.
Institutional Investors Weigh In On Xtant Medical
About Xtant Medical
Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.
Featured Stories
- Five stocks we like better than Xtant Medical
- The Role Economic Reports Play in a Successful Investment Strategy
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Industrial Products Stocks Investing
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Stock Average Calculator
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.